share_log

丰原药业:安徽径桥律师事务所关于公司2022年限制性股票激励计划第二个解除限售期解除限售条件成就、调整回购价格等相关事项的法律意见书

Fengyuan Pharmaceutical: Legal Opinion of Anhui Jingqiao Law Firm on the Company\'s 2022 Restricted Stock Incentive Plan\'s Second Cancellation Period, Achievements in Releasing Sales Restriction Conditions, Adjusting Repurchase Prices, etc.

SZSI ·  Oct 10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more